| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/08/2009 | EP1948661B1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 07/08/2009 | EP1592686B1 Gyrase inhibitors and uses thereof |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | CN101479273A Purinone derivatives as HM74A agonists |
| 07/08/2009 | CN101479272A Diketopyrrolopyrrole polymers as organic semiconductors |
| 07/08/2009 | CN101479271A Long wavelength shifted benzotriazole UV-absorbers and their use |
| 07/08/2009 | CN101479270A Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
| 07/08/2009 | CN101479269A Pteridine derivatives and their use as cathespin inhibitors |
| 07/08/2009 | CN101475573A Anti-influenza medicament oseltamivir phosphate intermediate, synthesizing method and use thereof |
| 07/08/2009 | CN100509814C Pemetrexed intermediate and preparation method thereof |
| 07/08/2009 | CN100509812C Process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/07/2009 | US7557125 Fab I inhibitors |
| 07/07/2009 | US7557120 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 07/07/2009 | US7557118 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one's and analogues, optionally mixed with acceptable carriers, excipients or diluents, used for treating multidrug resistant tumors, for inducing apoptosis and as immunology modulators |
| 07/07/2009 | US7557116 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1H-pyrano[2,3d 6,5-d′]dipyrimidyne and 10-aza-analogue thereof |
| 07/07/2009 | US7557113 5-{2-[(t-butoxy)carbonylamino]ethyl}-6-{3-chloro(2-thienyl)}-4-oxo-3-hydr- opyrrolo[3,2-d]pyrimidin-7-carboxyamide; GSK-3 inhibitor; diabetes, diabetic complications, Alzheimer's, neurodegenerative, manic depression, traumatic cerebrospinal injury, alopecia, inflammatory diseases, cancer, immunodeficienc |
| 07/07/2009 | US7557110 Pyrazolo[1,5-A] pyrimidine derivatives |
| 07/07/2009 | US7557099 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines |
| 07/07/2009 | CA2523261C Fused pyrimidine derivatives with crf activity |
| 07/07/2009 | CA2518195C Antitumor effect potentiator and antitumor agent |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
| 07/02/2009 | WO2009082687A1 Azaindolizines and methods of use |
| 07/02/2009 | WO2009082268A2 LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF |
| 07/02/2009 | WO2009082247A1 Process for preparing immucillins having a methylene link |
| 07/02/2009 | WO2009081197A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
| 07/02/2009 | WO2009080836A2 Macrocyclic indoles as hepatitis c virus inhibitors |
| 07/02/2009 | WO2009080682A1 Pyrrolo[2,3-d]pyrimidine derivatives as cgrp receptor antagonists |
| 07/02/2009 | WO2009080542A1 Process for the preparation of a macrocycle |
| 07/02/2009 | WO2009080534A1 Heterocyclic antiviral compounds |
| 07/02/2009 | WO2009079940A1 Method for transformation of crystal form of zopiclone |
| 07/02/2009 | WO2009079939A1 A method for preparing zopiclone |
| 07/02/2009 | WO2009079767A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer |
| 07/02/2009 | WO2009064802A3 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 07/02/2009 | WO2009063364A3 Modulators of urotensin receptor and methods of use thereof |
| 07/02/2009 | WO2009061676A3 Antagonists of pgd2 receptors |
| 07/02/2009 | WO2009013545A3 Chemical compounds |
| 07/02/2009 | WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 07/02/2009 | WO2008151735A3 Heterocyclically substituted heterocyclyl carboxylic acid derivatives |
| 07/02/2009 | WO2008068424A8 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 07/02/2009 | US20090170885 Naphthyridine derivatives as potassium channel modulators |
| 07/02/2009 | US20090170882 Methods and compositions |
| 07/02/2009 | US20090170878 Macrocyclic compounds useful as bace inhibitors |
| 07/02/2009 | US20090170859 Viral Polymerase Inhibitors |
| 07/02/2009 | US20090170856 Heterocyclic antiviral compounds |
| 07/02/2009 | US20090170854 New Use |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170844 Spiro Tetracyclic Compound |
| 07/02/2009 | US20090170833 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 07/02/2009 | US20090170831 Substituted lactams as inhibitors of abeta protein production |
| 07/02/2009 | US20090169558 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 07/02/2009 | US20090167167 Organic electroluminescent device and material for organic electroluminescent device |
| 07/02/2009 | CA2710644A1 Macrocyclic indoles as hepatitis c virus inhibitors |
| 07/02/2009 | CA2709536A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer |
| 07/02/2009 | CA2709514A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
| 07/02/2009 | CA2709348A1 Heterocyclic antiviral compounds |
| 07/02/2009 | CA2709032A1 Process for the preparation of a macrocycle |
| 07/02/2009 | CA2708176A1 Azaindolizines and methods of use |
| 07/01/2009 | EP2074998A2 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
| 07/01/2009 | EP2074127A1 Pyrazolo [1, 5-a]pyrimidine derivatives and their therapeutic use |
| 07/01/2009 | EP2074115A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| 07/01/2009 | EP2073799A2 Novel agents of calcium ion channel modulators |
| 07/01/2009 | EP1686999B1 Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
| 07/01/2009 | EP1594882B1 Process for preparing branched ribonucleosides from 1, 2-anhydroribofuranose intermediates |
| 07/01/2009 | CN101472927A Process for the preparation of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
| 07/01/2009 | CN101468989A [1,2,4] triazolo [4,3-a] pyridine compound with antiphlogistic activity and antimycotic activity |
| 07/01/2009 | CN100507563C N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination |
| 07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
| 06/30/2009 | US7553975 2-(((2-amino-1-oxo-3-mercapto-propyl)-amino)-methyl)-5-phenyl-thiazole-4-carbonyl-methionine; useful for treating restenosis or tissue proliferative diseases |
| 06/30/2009 | US7553861 Type-2 diabetes |
| 06/30/2009 | US7553839 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| 06/30/2009 | US7553836 7-(4-Chlorophenyl)-2-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one trifluoroacetic acid salt; obesity; antidiabetic agents; antidepressants; anxiolytic agents; combination with antipsychotic drugs enhanced therayp for schizophrenic disorders |
| 06/30/2009 | US7553833 3,3-spiroindolinone derivatives |
| 06/25/2009 | WO2009079412A2 Reverse transcriptase inhibitors |
| 06/25/2009 | WO2009078444A1 Preventive or therapeutic agent for inflammatory bowel disease |
| 06/25/2009 | WO2009077741A2 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents |
| 06/25/2009 | WO2009077527A1 Anthelmintic agents and their use |
| 06/25/2009 | WO2009077357A1 Spiroindolinone derivatives |
| 06/25/2009 | WO2009077334A1 Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 06/25/2009 | WO2009060292A3 Smac mimetic compounds as apoptosis inducers |
| 06/25/2009 | WO2009056692A3 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 06/25/2009 | WO2009034547A3 New 4-substituted derivatives of pyrazolo[3,4-d pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof |
| 06/25/2009 | US20090163714 P70 s6 kinase inhibitors |
| 06/25/2009 | US20090163713 Process for the preparation of 2-fluoroadenine |
| 06/25/2009 | US20090163706 Process for the preparation of a macrocycle |
| 06/25/2009 | US20090163565 Compounds with nootropic action, their preperation, pharmaceutical compositions containing them, and use thereof |
| 06/25/2009 | US20090163535 Substituted Heteroarylalkanoic Acids |
| 06/25/2009 | US20090163524 Novel Protein Kinase B Inhibitors - 060 |
| 06/25/2009 | US20090163523 Combinations comprising a s1p receptor agonist and a jak3 kinase inhibitor |
| 06/25/2009 | US20090163521 Novel Pyrazolopyrimidinone Derivatives |
| 06/25/2009 | US20090163520 MNK1 or MNK2 Inhibitors |
| 06/25/2009 | US20090163490 Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors |
| 06/25/2009 | US20090163489 Inhibitors of PI3 kinase |
| 06/25/2009 | US20090163468 Fused Bicyclic mTor Inhibitors |
| 06/25/2009 | US20090162319 Reverse transcriptase inhibitors |
| 06/25/2009 | DE102007061766A1 New 4-(4-cyano-2-thioaryl)-dihydro-pyrimidinone compounds are human neutrophil elastase inhibitor, useful for the treatment or prevention of e.g. pulmonary arterial hypertonia, acute lung injury and diseases of the cardiovascular system |
| 06/25/2009 | DE102007060172A1 New nitrogen substituted heterocyclic compounds are glycogen synthase kinase 3-beta inhibitors useful e.g. to treat and/or prevent hematological disease, preferably leukopenia, and for ex-vivo increase of adult hematopoietic stem cells |